STAGE IV PANCREATIC CANCER AJCC V8
Clinical trials for STAGE IV PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets tough pancreatic tumors
Disease control Not yet recruitingThis early-stage trial tests whether combining two drugs—selumetinib and DS-8201a—can safely shrink or control advanced pancreatic cancer that has a specific genetic change (KRAS mutation) and a protein called HER2. About 31 adults with cancer that cannot be removed by surgery or…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New drug combo targets cancers missing a key gene
Disease control Not yet recruitingThis study tests a new drug combination (BMS-986504 plus pemetrexed) in people with advanced solid tumors that have spread and are missing a gene called MTAP. The goal is to see if the combo is safe and can shrink or control the cancer. About 72 adults with certain digestive or o…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase trial is testing a new drug called AB801, combined with chemotherapy and immunotherapy, in people with bile duct or pancreatic cancer that is either advanced or has spread. The goal is to find the safest dose and see if the combination can shrink tumors. About 46…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New PET tracer could light up pancreatic tumors
Diagnosis Not yet recruitingThis early-phase trial tests a new radioactive tracer (64Cu-DOTA-A2DM) for PET scans in people with advanced pancreatic cancer that has spread. The tracer is designed to attach to a protein called PSCA found on some pancreatic cancer cells, making them visible on the scan. The st…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 12, 2026 12:06 UTC